Featured Publications
Mechanisms and Clinical Features of Co-Occurring Opioid and Nicotine Use
Lichenstein SD, Zakiniaeiz Y, Yip SW, Garrison KA. Mechanisms and Clinical Features of Co-Occurring Opioid and Nicotine Use. Current Addiction Reports 2019, 6: 114-125. PMID: 32864292, PMCID: PMC7451029, DOI: 10.1007/s40429-019-00245-3.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsNicotine useClinical featuresCholinergic systemUse disordersOpioid use disorderPurpose of ReviewToSubstance use disordersSex/gender considerationsRecent FindingsOpioidPathophysiological mechanismsSmoking cessationRisk factorsTreatment outcomesDrug rewardOpioidsFurther studiesHigh rateTreatmentDisordersHighlight areasPainReviewToEtiologyPharmacologicalCessation
2023
Examining the relationship of concurrent obesity and tobacco use disorder on the development of substance use disorders and psychiatric conditions: Findings from the NESARC-III
Fields L, Roberts W, Schwing I, McCoy M, Verplaetse T, Peltier M, Carretta R, Zakiniaeiz Y, Rosenheck R, McKee S. Examining the relationship of concurrent obesity and tobacco use disorder on the development of substance use disorders and psychiatric conditions: Findings from the NESARC-III. Drug And Alcohol Dependence Reports 2023, 7: 100162. PMID: 37159814, PMCID: PMC10163607, DOI: 10.1016/j.dadr.2023.100162.Peer-Reviewed Original ResearchTobacco use disorderSubstance use disordersBody mass indexUse disordersPsychiatric conditionsRisk of SUDAdditional substance use disordersSingle health conditionsRelated Conditions Wave IIIWorse health outcomesNational Epidemiological SurveyPsychiatric disorder diagnosisHarmful substance useDSM-5 criteriaConcurrent obesityComorbid obesityMass indexSUD diagnosisRisk factorsObesityComorbid diagnosesEpidemiological surveyHealth outcomesNESARC-IIIDisorder diagnosis